EFFECT OF TOBRAMYCIN INHALATION SOLUTION ON MORTALITY IN SUBGROUPS OF PATIENTS WITH CYSTIC FIBROSIS

被引:0
|
作者
Latremouille-Viau, D. [1 ]
Sawicki, G. S. [2 ]
Zhang, J. [3 ]
von Wartburg, M. [1 ]
Signorovitch, J. [1 ]
Wu, E. Q. [1 ]
Shi, L. [4 ]
机构
[1] Anal Grp Inc, Boston, MA USA
[2] Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Tulane Univ, New Orleans, LA 70118 USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:346 / 346
页数:1
相关论文
共 50 条
  • [1] Mortality of cystic fibrosis patients treated with tobramycin solution for inhalation
    Rothman, KJ
    Wentworth, CE
    [J]. EPIDEMIOLOGY, 2003, 14 (01) : 55 - 59
  • [2] Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
    Sawicki, Gregory S.
    Signorovitch, James E.
    Zhang, Jie
    Latremouille-Viau, Dominick
    von Wartburg, Markus
    Wu, Eric Q.
    Shi, Lizheng
    [J]. PEDIATRIC PULMONOLOGY, 2012, 47 (01) : 44 - 52
  • [3] Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature
    Hagerman, Jennifer K.
    Knechtel, Stephanie A.
    Klepser, Michael E.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 467 - 475
  • [4] Tobramycin Inhalation Solution (Bethkis) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1445): : 51 - 52
  • [5] Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis
    Wang, Xinting
    Koehne-Voss, Stephan
    Anumolu, SivaNaga S.
    Yu, Jing
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (11) : 3402 - 3409
  • [6] Tobramycin Inhalation Powder Is As Effective As Tobramycin Inhalation Solution In Patients With Cystic Fibrosis: A Subgroup Analysis Of The Eager Trial
    Konstan, M. W.
    Parkins, M.
    Angyalosi, G.
    Higgins, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis
    Gibson, Ronald L.
    Emerson, Julia
    Mayer-Hamblett, Nicole
    Burns, Jane L.
    McNamara, Sharon
    Accurso, Frank J.
    Konstan, Michael W.
    Chatfield, Barbara A.
    Retsch-Bogart, George
    Waltz, David A.
    Acton, James
    Zeitlin, Pamela
    Hiatt, Peter
    Moss, Richard
    Williams, Judy
    Ramsey, Bonnie W.
    Grp, Tobramycin In Young Children Study
    [J]. PEDIATRIC PULMONOLOGY, 2007, 42 (07) : 610 - 623
  • [8] Tobramycin Inhalation Solution Prescribing Practices in Non-Cystic Fibrosis Pediatric Patients
    Shenoy, A. R.
    Noval, M.
    Chan, S.
    Ravin, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] TOBRAMYCIN INHALATION POWDER VS TOBRAMYCIN INHALATION SOLUTION FOR CYSTIC FIBROSIS: RESPONSE BY AGE GROUP IN THE EAGER TRIAL
    Geller, D. E.
    Nasr, S.
    Piggott, S.
    Angyalosi, G.
    Higgins, M.
    [J]. PEDIATRIC PULMONOLOGY, 2011, : 337 - 338
  • [10] Inhalation of tobramycin in patients with cystic fibrosis:: Comparison of two methods
    Dopfer, R.
    Brand, P.
    Muellinger, B.
    Hunger, T.
    Haeussermann, S.
    Meyer, T.
    Scheuch, G.
    Siekmeier, R.
    [J]. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 58 : 141 - 154